Mutations in GPI pathway proteins have been linked to a wide variety of rare genetic disorders (Bellai-Dussault et al., 2019), while mutations in PGAP2 specifically have been shown to cause to intellectual disability, hyperphosphatasia, and petit mal seizures (Hansen et al., 2013). The gene discussed is PGAP2; the disease is hereditary disease.